These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
157 related articles for article (PubMed ID: 910879)
21. Strategies for reducing prescription costs. Chilton L Pediatrics; 1981 Nov; 68(5):713-6. PubMed ID: 7312476 [No Abstract] [Full Text] [Related]
22. Drug product selection and the law. Fink JL Contemp Pharm Pract; 1979; 2(3):128-31. PubMed ID: 10242846 [TBL] [Abstract][Full Text] [Related]
23. Opinions of pharmacy, medicine, and pharmaceutical industry leaders about hypothetical therapeutic-interchange legislation. Segal R; Grines LL; Pathak DS Am J Hosp Pharm; 1988 Mar; 45(3):570-7. PubMed ID: 3369459 [TBL] [Abstract][Full Text] [Related]
24. How to pay less for prescription drugs. Consum Rep; 1975 Jan; 40(1):48-53. PubMed ID: 1244036 [No Abstract] [Full Text] [Related]
25. Drug product selection legislation: a comparative analysis. Wetherbee H; Sharpe TR Am J Pharm Sci Support Public Health; 1978; 150(6):171-6. PubMed ID: 576098 [No Abstract] [Full Text] [Related]
26. Physicians' attitudes toward and knowledge about generic drug substitution. Friedman D; Jaffe A; Steinhardt S N Y State J Med; 1987 Oct; 87(10):539-42. PubMed ID: 3479720 [No Abstract] [Full Text] [Related]
27. Physician-ownership in pharmacies and drug repackagers. Hoffer GE Inquiry; 1975 Mar; 12(1):26-36. PubMed ID: 123219 [No Abstract] [Full Text] [Related]
28. 25th annual prescription survey: Albany College of Pharmacy of Union University. DeNuzzo RV Med Mark Media; 1981 Apr; 16(4):31-2, 34-51. PubMed ID: 10250762 [No Abstract] [Full Text] [Related]
29. Joint statement on antisubstitution laws and regulations. JAMA; 1973 Jul; 225(2):142. PubMed ID: 4740275 [No Abstract] [Full Text] [Related]
30. More states adopt generic substitution laws. Goldsmith LS J Leg Med (N Y); 1977 Oct; 5(10):31-2. PubMed ID: 303272 [No Abstract] [Full Text] [Related]
31. Philosophy, prescriptions, and politics. Bess DR JAMA; 1980 Feb; 243(6):525-7. PubMed ID: 7351782 [No Abstract] [Full Text] [Related]
32. Keeping prescription drugs safe and effective. Bryan PA Am Fam Physician; 1974 Nov; 10(5):189-93. PubMed ID: 4421343 [No Abstract] [Full Text] [Related]
33. Drug substitution--boon to consumers versus legal trap for the professional. Brennan BJ J Leg Med (N Y); 1976 Mar; 4(3):20-5. PubMed ID: 1083405 [No Abstract] [Full Text] [Related]
34. In defense of the Drug Research Board. Azarnoff DL JAMA; 1975 Aug; 233(5):425-6. PubMed ID: 1173852 [No Abstract] [Full Text] [Related]
35. Holding down prescription drug costs. FDA Consum; 1975 Dec-1976 Jan; 9(10):9-10. PubMed ID: 10305011 [No Abstract] [Full Text] [Related]
36. The Ohio Generic Product Selection Law: influence on pharmacy practice. Hunter RH Med Mark Media; 1979 Jul; 14(7):33-6. PubMed ID: 10243269 [No Abstract] [Full Text] [Related]
37. Drug product selection: the Florida experience. Vuturo GJ; Krischer JP; McCormick WC Am J Public Health; 1980 May; 70(5):479-84. PubMed ID: 7377418 [TBL] [Abstract][Full Text] [Related]
38. Achieving prescription drug savings. Wilensky GR Health Aff (Millwood); 1990; 9(4):222. PubMed ID: 2289758 [No Abstract] [Full Text] [Related]
39. Guidelines for pharmacists performing product selection. Am Pharm; 1990 Jul; NS30(7):40-1. PubMed ID: 2363394 [No Abstract] [Full Text] [Related]
40. Generic warfarin: implications for clinical practice and perceptions of anticoagulation providers. Bongiorno RA; Nutescu EA Semin Thromb Hemost; 2004 Dec; 30(6):619-26. PubMed ID: 15630667 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]